Skip to content
OpenCapital
Get started

Rhythm Pharmaceuticals, Inc. RYTM Quick ratio

Quick ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.1×0.0×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
2×-1.1×
Arrowhead Research logo
Arrowhead ResearchARWR
6.2×+1.1×
Alkermes logo
AlkermesALKS
1.7×-1.2×
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
15.9×+7.4×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.1×

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K—
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$6.64B+77.3%
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.

quick assets/total current liabilities=3.9×

Based on the most recent quarter.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s quick ratio?
Rhythm Pharmaceuticals, Inc. (RYTM) reported quick ratio of 3.9× in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s quick ratio changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s quick ratio increased by 24.3% year-over-year, from 3.1× to 3.9×.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s quick ratio has grown at a -16.2% compound annual growth rate (CAGR), from 10.1× to 4.2×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.